(COV) Covivio - Overview
Sector: Real Estate | Industry: REIT - Diversified | Exchange: PA (France) | Market Cap: 6.137m EUR | Total Return: 9.1% in 12m
Offices, Hotels, Residential Housing
Total Rating 42
Safety 54
Buy Signal -0.72
REIT - Diversified
Industry Rotation: +0.8
Industry Rotation: +0.8
Market Cap:
7.19B
Avg Turnover: 7.12M
Avg Turnover: 7.12M
Risk 3d forecast
Volatility26.8%
VaR 5th Pctl4.58%
VaR vs Median3.49%
Reward TTM
Sharpe Ratio0.30
Rel. Str. IBD29.1
Rel. Str. Peer Group42
Character TTM
Beta0.216
Beta Downside0.023
Hurst Exponent0.602
Drawdowns 3y
Max DD21.91%
CAGR/Max DD0.38
CAGR/Mean DD1.11
Warnings
Altman Z'' 0.07 < 1.0 - financial distress zone
Tailwinds
No distinct edge detected
Description: COV Covivio
Covivio SA is a French-based real estate investment trust (REIT) that manages a multi-sector portfolio across major European markets. Founded in 1963, the company operates with a diversified business model that integrates office spaces, hotels, and residential properties into a unified urban development strategy.
The company functions as both an owner and operator, focusing on long-term asset appreciation and rental income through the work, live, travel concept. Diversified REITs like Covivio benefit from risk mitigation by balancing performance across different real estate cycles and asset classes. The firm emphasizes environmental and social governance (ESG) to enhance the long-term attractiveness and transformation of its physical holdings.
Investors can evaluate the underlying fundamentals and valuation metrics of this portfolio on ValueRay. Given its significant footprint in France, Germany, and Italy, Covivio remains a central player in the consolidation of the European commercial and hospitality real estate sectors.
- European interest rate shifts impact net asset value and debt financing costs
- Office occupancy rates in major European cities drive core rental income growth
- Strategic divestment of non-core assets supports balance sheet deleveraging and liquidity
- Hotel revenue recovery and RevPAR growth influence hospitality segment earnings volatility
- Regulatory changes in German residential rent controls impact long-term portfolio yields
Piotroski VR‑10 (Strict)
5.0
| Net Income: 806.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA -0.16 > 1.0 |
| NWC/Revenue: -71.82% < 20% (prev 6.74%; Δ -78.56% < -1%) |
| CFO/TA 0.06 > 3% & CFO 1.56b > Net Income 806.9m |
| Net Debt (9.43b) to EBITDA (1.66b): 5.67 < 3 |
| Current Ratio: 0.44 > 1.5 & < 3 |
| Outstanding Shares: last quarter (110.8m) vs 12m ago 10.65% < -2% |
| Gross Margin: 63.87% > 18% (prev 0.73%; Δ 6.31k% > 0.5%) |
| Asset Turnover: 9.82% > 50% (prev 11.19%; Δ -1.37% > 0%) |
| Interest Coverage Ratio: 38.66 > 6 (EBITDA TTM 1.66b / Interest Expense TTM 27.4m) |
Altman Z''
0.07
| A: -0.06 (Total Current Assets 1.21b - Total Current Liabilities 2.77b) / Total Assets 25.34b |
| B: 0.03 (Retained Earnings 738.7m / Total Assets 25.34b) |
| C: 0.05 (EBIT TTM 1.06b / Avg Total Assets 22.23b) |
| D: 0.06 (Book Value of Equity 738.7m / Total Liabilities 12.69b) |
| Altman-Z'' Score: 0.07 = B |
Beneish M
-3.35
| DSRI: 0.46 (Receivables 226.5m/481.4m, Revenue 2.18b/2.14b) |
| GMI: 1.15 (GM 63.87% / 73.36%) |
| AQI: 1.01 (AQ_t 0.87 / AQ_t-1 0.87) |
| SGI: 1.02 (Revenue 2.18b / 2.14b) |
| TATA: -0.03 (NI 806.9m - CFO 1.56b) / TA 25.34b) |
| Beneish M-Score: -3.35 (Cap -4..+1) = AA |
What is the price of COV shares?
As of May 16, 2026, the stock is trading at EUR 53.10 with a total of 84,833 shares traded.
Over the past week, the price has changed by -4.15%, over one month by -9.39%, over three months by -3.75% and over the past year by +9.13%.
Over the past week, the price has changed by -4.15%, over one month by -9.39%, over three months by -3.75% and over the past year by +9.13%.
Is COV a buy, sell or hold?
Covivio has no consensus analysts rating.
What are the forecasts/targets for the COV price?
| Analysts Target Price | - | - |
Covivio (COV) - Fundamental Data Overview
as of 11 May 2026
Market Cap USD = 7.19b (6.14b EUR * 1.1715 EUR.USD)P/E Trailing = 8.356
P/E Forward = 11.1235
P/S = 5.3547
P/B = 0.7124
P/EG = 24.6239
Revenue TTM = 2.18b EUR
EBIT TTM = 1.06b EUR
EBITDA TTM = 1.66b EUR
Long Term Debt = 8.66b EUR (from longTermDebt, last quarter)
Short Term Debt = 1.98b EUR (from shortLongTermDebt, last quarter)
Debt = 10.63b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 9.43b EUR (from netDebt column, last quarter)
Enterprise Value = 15.56b EUR (6.14b + Debt 10.63b - CCE 1.21b)
Interest Coverage Ratio = 38.66 (Ebit TTM 1.06b / Interest Expense TTM 27.4m)
EV/FCF = 33.48x (Enterprise Value 15.56b / FCF TTM 464.8m)
FCF Yield = 2.99% (FCF TTM 464.8m / Enterprise Value 15.56b)
FCF Margin = 21.30% (FCF TTM 464.8m / Revenue TTM 2.18b)
Net Margin = 36.97% (Net Income TTM 806.9m / Revenue TTM 2.18b)
Gross Margin = 63.87% ((Revenue TTM 2.18b - Cost of Revenue TTM 788.6m) / Revenue TTM)
Gross Margin QoQ = 70.12% (prev 62.50%)
Tobins Q-Ratio = 0.61 (Enterprise Value 15.56b / Total Assets 25.34b)
Interest Expense / Debt = 0.26% (Interest Expense 27.4m / Debt 10.63b)
Taxrate = 25.0% (EU avg default 25%)
NOPAT = 794.4m (EBIT 1.06b * (1 - 25.00%))
Current Ratio = 0.44 (Total Current Assets 1.21b / Total Current Liabilities 2.77b)
Debt / Equity = 1.23 (Debt 10.63b / totalStockholderEquity, last quarter 8.61b)
Debt / EBITDA = 5.67 (Net Debt 9.43b / EBITDA 1.66b)
Debt / FCF = 20.28 (Net Debt 9.43b / FCF TTM 464.8m)
Total Stockholder Equity = 8.30b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.63% (Net Income 806.9m / Total Assets 25.34b)
RoE = 9.72% (Net Income TTM 806.9m / Total Stockholder Equity 8.30b)
RoCE = 6.25% (EBIT 1.06b / Capital Employed (Equity 8.30b + L.T.Debt 8.66b))
RoIC = 4.17% (NOPAT 794.4m / Invested Capital 19.07b)
WACC = 2.59% (E(6.14b)/V(16.77b) * Re(6.74%) + D(10.63b)/V(16.77b) * Rd(0.26%) * (1-Tc(0.25)))
Discount Rate = 6.74% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares (quarterly) Correlation: 82.22 | Cagr: 7.44%
[DCF] Terminal Value 88.22% ; FCFF base≈431.5m ; Y1≈519.6m ; Y5≈838.7m
[DCF] Fair Price = 135.1 (EV 24.39b - Net Debt 9.43b = Equity 14.97b / Shares 110.8m; r=6.0% [WACC]; 5y FCF grow 21.81% → 3.0% )
EPS Correlation: 19.10 | EPS CAGR: 31.77% | SUE: N/A | # QB: 0
Revenue Correlation: 41.42 | Revenue CAGR: 16.03% | SUE: 0.21 | # QB: 0
EPS current Year (2026-12-31): EPS=4.94 | Chg30d=+2.18% | Revisions=+20% | GrowthEPS=+8.1% | GrowthRev=+56.6%
EPS next Year (2027-12-31): EPS=5.05 | Chg30d=+0.01% | Revisions=+0% | GrowthEPS=+2.2% | GrowthRev=+6.3%
[Analyst] Revisions Ratio: +20%